Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 11, 2016 ) lmonary Dysplasia - Pipeline Review, H1 2014
Summary
Global Markets Directs, Bronchopulmonary Dysplasia - Pipeline Review, H1 2014, provides an overview of the Bronchopulmonary Dysplasias therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Bronchopulmonary Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bronchopulmonary Dysplasia and special features on late-stage and discontinued projects.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=198028
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Bronchopulmonary Dysplasia Overview 6 Therapeutics Development 7 Pipeline Products for Bronchopulmonary Dysplasia - Overview 7 Pipeline Products for Bronchopulmonary Dysplasia - Comparative Analysis 8 Bronchopulmonary Dysplasia - Therapeutics under Development by Companies 9 Bronchopulmonary Dysplasia - Therapeutics under Investigation by Universities/Institutes 11 Bronchopulmonary Dysplasia - Pipeline Products Glance 12 Late Stage Products 12 Clinical Stage Products 13 Early Stage Products 14 Bronchopulmonary Dysplasia - Products under Development by Companies 15 Bronchopulmonary Dysplasia - Products under Investigation by Universities/Institutes 16 Bronchopulmonary Dysplasia - Companies Involved in Therapeutics Development 17 Chiesi Farmaceutici SpA 17 MediPost Co., Ltd. 18 Syntrix Biosystems, Inc. 19 Ikaria Inc. 20 Clarassance, Inc. 21 Bronchopulmonary Dysplasia - Therapeutics Assessment 22 Assessment by Monotherapy Products 22 Assessment by Target 23
Contact Us:
Mr. Nachiket Albany NY, United States - 12207 Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free) Email: sales@researchmoz.us Follow us on LinkedIn at: http://bit.ly/1TBmnVG Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|